DelOrefice Christopher 4

What Happened

• Christopher DelOrefice, CFO of Ulta Beauty (ULTA), was granted equity awards on March 31, 2026: 4,219 restricted shares (awarded at $0.00) and a derivative award representing rights to purchase 14,363 shares (reported at $0.00). These are grants (awards), not open-market purchases or sales, and no cash was paid on receipt.

Key Details

• Transaction date: March 31, 2026; Form 4 filed April 2, 2026 (timely filing within the two-business-day requirement).
• Award specifics: 4,219 restricted stock shares (price $0.00); 14,363-option equivalent (derivative award, price $0.00).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — the 4,219 restricted shares vest 100% on March 15, 2029. F2 — the 14,363-option right vests 25% per year starting March 15, 2027, with remaining vesting each anniversary through March 15, 2030.
• Transaction code: A (award/grant).

Context

• These grants are compensation awards (intended for retention/long-term incentive) rather than purchases or sales; they do not represent immediate cash investment or disposition. The derivative entry reflects a right to purchase shares that will vest over time rather than an exercised option or immediate ownership change.